Cargando…
Pharmacologically reversible, loss of function mutations in the TM2 and TM4 inner pore helices of TREK-1 K2P channels
A better understanding of the gating of TREK two pore domain potassium (K2P) channels and their activation by compounds such as the negatively charged activator, flufenamic acid (FFA) is critical in the search for more potent and selective activators of these channels. Currents through wild-type and...
Autores principales: | Al-Moubarak, Ehab, Veale, Emma L., Mathie, Alistair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712037/ https://www.ncbi.nlm.nih.gov/pubmed/31455781 http://dx.doi.org/10.1038/s41598-019-48855-1 |
Ejemplares similares
-
The Prostacyclin Analogue, Treprostinil, Used in the Treatment of Pulmonary Arterial Hypertension, is a Potent Antagonist of TREK-1 and TREK-2 Potassium Channels
por: Cunningham, Kevin P., et al.
Publicado: (2021) -
Block of TREK and TRESK K2P channels by lamotrigine and two derivatives sipatrigine and CEN-092
por: Walsh, Yvonne, et al.
Publicado: (2021) -
Trafficking of Neuronal Two Pore Domain Potassium Channels
por: Mathie, Alistair, et al.
Publicado: (2010) -
Activation of TREK currents by riluzole in three subgroups of cultured mouse nodose ganglion neurons
por: Fernández-Fernández, Diego, et al.
Publicado: (2018) -
Activation of TREK-1, but Not TREK-2, Channel by Mood Stabilizers
por: Kim, Eun-Jin, et al.
Publicado: (2017)